Depression - New Orleans LA

Summary:

Click image to enlarge

If you’ve been struggling in a depressive episode for the last 4 weeks or more, we need your help to study a new treatment for depression. 

This study is working with a medication that’s already FDA approved to treat other conditions. The treatment is an NDRI (norepinephrine & dopamine reuptake inhibitor), a class of antidepressants that includes popular brand names such as Lexapro® and Wellbutrin®.

Currently enrolling for ages 18-65. 

Must not have an additional psychological diagnosis that may cause depression-like symptoms, such as Bipolar Disorder or Bipolar Depression, Schizophrenia, or Obsessive-Compulsive Disorder. 

Space is very limited for this study. Apply now! 

Qualified Participants May Receive:

Qualified participants will receive free study-related care for the duration of the program. Compensation for your time and travel is available once enrolled, up to $750.